BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21332319)

  • 1. Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.
    Hwang R; Souza RP; Tiwari AK; Zai CC; Müller DJ; Potkin SG; Lieberman JA; Meltze HY; Kennedy JL
    Pharmacogenomics; 2011 Feb; 12(2):277-91. PubMed ID: 21332319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.
    Ma L; Zhang X; Xiang Q; Zhou S; Zhao N; Xie Q; Zhao X; Zhou Y; Cui Y
    Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):94-104. PubMed ID: 30103286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
    Zainal Abidin S; Tan EL; Chan SC; Jaafar A; Lee AX; Abd Hamid MH; Abdul Murad NA; Pakarul Razy NF; Azmin S; Ahmad Annuar A; Lim SY; Cheah PS; Ling KH; Mohamed Ibrahim N
    BMC Neurol; 2015 Apr; 15():59. PubMed ID: 25896831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study on pathological gambling and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in a Korean population.
    Lim S; Ha J; Choi SW; Kang SG; Shin YC
    J Gambl Stud; 2012 Sep; 28(3):481-91. PubMed ID: 21853233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.
    Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J
    Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
    Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia.
    Novak G; LeBlanc M; Zai C; Shaikh S; Renou J; DeLuca V; Bulgin N; Kennedy JL; Le Foll B
    Ann Hum Genet; 2010 Jul; 74(4):291-8. PubMed ID: 20456319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking Genes: A Case-Control Study of Dopamine Transporter Gene (
    Ruzilawati AB; Islam MA; Muhamed SKS; Ahmad I
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the DRD2 CA
    Xu S; Liu J; Yang X; Qian Y; Xiao Q
    J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
    Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
    Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
    Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller HJ; Propping P; Nöthen MM
    Neuropsychopharmacology; 1996 Nov; 15(5):491-6. PubMed ID: 8914122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.
    Scharfetter J; Chaudhry HR; Hornik K; Fuchs K; Sieghart W; Kasper S; Aschauer HN
    Eur Neuropsychopharmacol; 1999 Dec; 10(1):17-20. PubMed ID: 10647091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.
    Yang B; Niu W; Chen S; Xu F; Li X; Wu X; Cao Y; Zhang R; Yang F; Wang L; Li W; Xu Y; He L; He G
    Psychiatry Res; 2016 Nov; 245():361-364. PubMed ID: 27591410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.
    Hwang R; Zai C; Tiwari A; Müller DJ; Arranz MJ; Morris AG; McKenna PJ; Munro J; Potkin SG; Lieberman JA; Meltzer HY; Kennedy JL
    Pharmacogenomics J; 2010 Jun; 10(3):200-18. PubMed ID: 20029384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.
    Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.